Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
ARTH similar filings
- 31 Jan 14 Arch Therapeutics Announces $2.85 Million Private Placement
- 4 Oct 13 Entry into a Material Definitive Agreement
- 8 Jul 13 Arch Therapeutics Appoints Senior Management Team Members
- 26 Jun 13 Report of Independent Registered Public Accounting Firm
- 24 Jun 13 Departure of Directors or Certain Officers
- 5 Jun 13 Amendments to Articles of Incorporation or Bylaws
- 24 May 13 Other Events
Filing view
External links
June 26, 2013
Securities and Exchange Commission
Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K of Arch Therapeutics, Inc. dated June 26, 2013. We agree with the statements made concerning our firm contained therein.
Yours very truly,
/s/ Paritz & Company, P.A.
Paritz & Company, P.A.